Progress and Viewpoints of Multifunctional Composite Nanomaterials for Glioblastoma Theranostics

The most common malignant tumor of the brain is glioblastoma multiforme (GBM) in adults. Many patients die shortly after diagnosis, and only 6% of patients survive more than 5 years. Moreover, the current average survival of malignant brain tumors is only about 15 months, and the recurrence rate wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Ming-Hsien, Huang, Wen-Tse, Satpathy, Aishwarya, Su, Ting-Yi, Hsiao, Michael, Liu, Ru-Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875488/
https://www.ncbi.nlm.nih.gov/pubmed/35214188
http://dx.doi.org/10.3390/pharmaceutics14020456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875488/
https://www.ncbi.nlm.nih.gov/pubmed/35214188
http://dx.doi.org/10.3390/pharmaceutics14020456

Ejemplares similares